Blackstone Life Sciences Announces Collaboration to Support Moderna's Influenza Program
March 28, 2024
March 28, 2024
NEW YORK, March 28 -- Blackstone, an investment firm, issued the following news release on March 27, 2024:
Blackstone (NYSE:BX) announced today a new collaboration with Moderna, Inc. (NASDAQ: MRNA, "Moderna") through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences ("Blackstone") will provide up to $750 million to fund Moderna's influenza ("flu") program.
"Moderna has demonstrated a . . .
Blackstone (NYSE:BX) announced today a new collaboration with Moderna, Inc. (NASDAQ: MRNA, "Moderna") through a development and commercialization funding agreement where funds managed by Blackstone Life Sciences ("Blackstone") will provide up to $750 million to fund Moderna's influenza ("flu") program.
"Moderna has demonstrated a . . .